118 related articles for article (PubMed ID: 6488590)
1. Suramin inhibits the binding of complement-fixing antibody/double-stranded DNA immune complexes to CR1.
Taylor RP; Horgan C; Harbin A; Burge J
Clin Immunol Immunopathol; 1984 Nov; 33(2):220-31. PubMed ID: 6488590
[TBL] [Abstract][Full Text] [Related]
2. Release of immune complexes bound to CR1 on erythrocytes; suramin inhibits factor I in the presence of EDTA.
Thomsen BS; Nielsen H; Bendixen G
Allergy; 1986 Sep; 41(7):487-92. PubMed ID: 2947512
[TBL] [Abstract][Full Text] [Related]
3. Interaction of complement-solubilized immune complexes (IC) with CR1 receptors on human erythrocytes. Polysulfated compounds inhibit IC binding and induce IC-release from CR1.
Jepsen HH; Ekre HP; Svehag SE
Int J Immunopharmacol; 1987; 9(5):587-95. PubMed ID: 2442111
[TBL] [Abstract][Full Text] [Related]
4. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes.
Taylor RP; Pocanic F; Reist C; Wright EL
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):143-60. PubMed ID: 1833104
[TBL] [Abstract][Full Text] [Related]
5. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
Ng YC; Schifferli JA; Walport MJ
Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
[TBL] [Abstract][Full Text] [Related]
6. Studies on the kinetics of binding of complement-fixing dsDNA/anti-dsDNA immune complexes to the red blood cells of normal individuals and patients with systemic lupus erythematosus.
Horgan C; Taylor RP
Arthritis Rheum; 1984 Mar; 27(3):320-9. PubMed ID: 6546694
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes.
Emlen W; Carl V; Burdick G
Clin Exp Immunol; 1992 Jul; 89(1):8-17. PubMed ID: 1385769
[TBL] [Abstract][Full Text] [Related]
8. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
Madi N; Paccaud JP; Steiger G; Schifferli JA
Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of interaction between complement-fixing antibody/dsDNA immune complexes and erythrocytes. In vitro studies and potential general applications to clinical immune complex testing.
Taylor RP; Horgan C; Hooper M; Burge J
J Clin Invest; 1985 Jan; 75(1):102-11. PubMed ID: 3917462
[TBL] [Abstract][Full Text] [Related]
10. Interaction of complement-solubilized immune complexes with CR1 receptors on human erythrocytes. The binding reaction.
Jepsen HH; Svehag SE; Jarlbaek L; Baatrup G
Scand J Immunol; 1986 Jan; 23(1):65-73. PubMed ID: 2939551
[TBL] [Abstract][Full Text] [Related]
11. Immune complexes bind preferentially to specific subpopulations of human erythrocytes.
Cosio FG; Shen XP; Hebert LA
Clin Immunol Immunopathol; 1990 Jun; 55(3):337-54. PubMed ID: 2140304
[TBL] [Abstract][Full Text] [Related]
12. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
Pascual M; Schifferli JA
Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of non-human primate erythrocyte immune adherence receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system.
Edberg JC; Kimberly RP; Taylor RP
Eur J Immunol; 1992 Jun; 22(6):1333-9. PubMed ID: 1376254
[TBL] [Abstract][Full Text] [Related]
14. A complement receptor for opsonized immune complexes on erythrocytes from Oncorhynchus mykiss but not Ictalarus punctatus.
Schraml B; Baker MA; Reilly BD
Mol Immunol; 2006 Apr; 43(10):1595-603. PubMed ID: 16271392
[TBL] [Abstract][Full Text] [Related]
15. The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.
Taylor RP; Burge J; Horgan C; Shasby DM
J Immunol; 1983 Jun; 130(6):2656-62. PubMed ID: 6854016
[TBL] [Abstract][Full Text] [Related]
16. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
Lucisano Valim YM; Lachmann PJ
Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
[TBL] [Abstract][Full Text] [Related]
17. Physiological and pathological aspects of circulating immune complexes.
Schifferli JA; Taylor RP
Kidney Int; 1989 Apr; 35(4):993-1003. PubMed ID: 2651776
[TBL] [Abstract][Full Text] [Related]
18. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
Emlen W; Burdick G; Carl V; Lachmann PJ
J Immunol; 1989 Jun; 142(12):4366-71. PubMed ID: 2524529
[TBL] [Abstract][Full Text] [Related]
19. Binding to erythrocyte complement receptor type 1 of BSA/anti-BSA complexes opsonized by C4A3 or C4B1 in the presence of serum.
Klint C; Truedsson L; Sturfelt G
Scand J Immunol; 1995 Oct; 42(4):425-32. PubMed ID: 7569775
[TBL] [Abstract][Full Text] [Related]
20. Binding and catabolism of aggregated immunoglobulins bearing C3b or iC3b by U937 cells.
Daha MR; Gorter A; Leijh PJ; Klar N; van Es LA
Immunology; 1988 Jul; 64(3):375-9. PubMed ID: 2970428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]